Literature DB >> 26318020

Reversible vascular calcifications associated with hypervitaminosis D.

Massimo Cirillo1, Giancarlo Bilancio2, Chiara Cirillo3.   

Abstract

A 64-year-old man was hospitalized in 2002 with symptoms of stupor, weakness, and renal colic. The clinical examination indicated borderline hypertension, small masses in the glutei, and polyuria. Laboratory tests evidenced high serum concentrations of creatinine, calcium, and phosphate. Imaging assessments disclosed widespread vascular calcifications, gluteal calcifications, and pelvic ectasia. Subsequent lab tests indicated suppressed serum parathyroid hormone, extremely high serum 25-hydroxy vitamin D, and normal serum 1,25-dihydroxy vitamin D. Treatment was started with intravenous infusion of saline and furosemide due to the evidence of hypercalcemia. Prednisone and omeprazole were added given the evidence of hypervitaminosis D. The treatment improved serum calcium, kidney function, and consciousness. The medical history disclosed recent treatment with exceptionally high doses of slow-release intra-muscular cholecalciferol and the recent excretion of urinary stones. The patient was discharged when it was possible to stop the intravenous treatment. The post-discharge treatment included oral hydration, furosemide, prednisone and omeprazole for approximately 6 months up to complete resolution of the hypercalcemia. The patient came back 12 years later because of microhematuria. Lab tests were normal for calcium/phosphorus homeostasis and kidney function. Imaging tests indicated only minor vascular calcifications. This is the first evidence of reversible vascular calcifications secondary to hypervitaminosis D.

Entities:  

Keywords:  Cholecalciferol; Hypercalcemia; Vascular calcification; Vitamin D

Mesh:

Substances:

Year:  2015        PMID: 26318020     DOI: 10.1007/s40620-015-0228-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  11 in total

Review 1.  The role of phosphorus in the development and progression of vascular calcification.

Authors:  Jessica Kendrick; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2011-09-28       Impact factor: 8.860

2.  Aortic calcification produced by vitamin D3 plus nicotine.

Authors:  N Niederhoffer; Y V Bobryshev; I Lartaud-Idjouadiene; P Giummelly; J Atkinson
Journal:  J Vasc Res       Date:  1997 Sep-Oct       Impact factor: 1.934

Review 3.  Hypercalcemia and metastatic calcification.

Authors:  D N Kerr
Journal:  Cardiovasc Res       Date:  1997-12       Impact factor: 10.787

Review 4.  Media calcification and intima calcification are distinct entities in chronic kidney disease.

Authors:  Kerstin Amann
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

5.  Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.

Authors:  J A Kanis; R G Russell
Journal:  Br Med J       Date:  1977-01-08

6.  Progressively increased serum 1,25-dihydroxyvitamin D2 concentration in a hypoparathyroid patient with protracted hypercalcemia due to vitamin D2 intoxication.

Authors:  K Sato; N Emoto; S Toraya; T Tsushima; H Demura; N Tsuji; S Inaba; A Takeuchi; T Kobayashi
Journal:  Endocr J       Date:  1994-08       Impact factor: 2.349

7.  Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function.

Authors:  Alicia Bas; Ignacio Lopez; Jose Perez; Mariano Rodriguez; Escolastico Aguilera-Tejero
Journal:  J Bone Miner Res       Date:  2005-12-19       Impact factor: 6.741

8.  The osteodystrophy of hypervitaminosis D: a metabolic study.

Authors:  M Davies; E B Mawer; A J Freemont
Journal:  Q J Med       Date:  1986-10

9.  Calcinosis of joints and periarticular tissues associated with vitamin D intoxication.

Authors:  R C Butler; P A Dieppe; A C Keat
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

Review 10.  Vitamin D treatment and mortality in chronic kidney disease: a systematic review and meta-analysis.

Authors:  Flore Duranton; Maria E Rodriguez-Ortiz; Yohan Duny; Mariano Rodriguez; Jean-Pierre Daurès; Angel Argilés
Journal:  Am J Nephrol       Date:  2013-03-05       Impact factor: 3.754

View more
  2 in total

Review 1.  A review of the growing risk of vitamin D toxicity from inappropriate practice.

Authors:  Peter N Taylor; J Stephen Davies
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

2.  Vitamin D Toxicity Managed with Peritoneal Dialysis.

Authors:  Krystel Feghali; Kostas Papamarkakis; Jackson Clark; Neha Malhotra; Lanu Stoddart; Ibitoro Osakwe
Journal:  Case Rep Endocrinol       Date:  2021-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.